Position 5-7: Finalization

Peritoneal Cavity

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 0

Open

Device 5

3E0M05Z Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Open Approach
Approach 3

Percutaneous

Device 0

3E0M304 Introduction Peritoneal Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
3E0M305 Introduction Peritoneal Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach
3E0M30M Introduction Peritoneal Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
3E0M30Y Introduction Peritoneal Cavity to Hyperthermic with Antineoplastic, Percutaneous Approach

Device 2

3E0M328 Introduction Peritoneal Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach
3E0M329 Introduction Peritoneal Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach

Device 3

3E0M33Z Introduction Peritoneal Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach

Device 5

3E0M35Z Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Percutaneous Approach

Device 6

3E0M36Z Introduction Peritoneal Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach

Device 7

3E0M37Z Introduction Peritoneal Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach

Device B

3E0M3BZ Introduction Peritoneal Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach

Device G

3E0M3GC Introduction Peritoneal Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach

Device H

3E0M3HZ Introduction Peritoneal Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach

Device K

3E0M3KZ Introduction Peritoneal Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach

Device N

3E0M3NZ Introduction Peritoneal Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach

Device S

3E0M3SF Introduction Peritoneal Cavity to Other Gas with Gas, Percutaneous Approach

Device T

3E0M3TZ Introduction Peritoneal Cavity to No Qualifier with Destructive Agent, Percutaneous Approach
Approach 4

Percutaneous Endoscopic

Device 5

3E0M45Z Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Percutaneous Endoscopic Approach

Device G

3E0M4GC Introduction Peritoneal Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
Approach 7

Via Natural or Artificial Opening

Device 0

3E0M704 Introduction Peritoneal Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
3E0M705 Introduction Peritoneal Cavity to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
3E0M70M Introduction Peritoneal Cavity to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach

Device S

3E0M7SF Introduction Peritoneal Cavity to Other Gas with Gas, Via Natural or Artificial Opening Approach